# Study in Localized and Disseminated Ewing Sarcoma

> **NCT00987636** · PHASE3 · COMPLETED · sponsor: **University Hospital Muenster** · enrollment: 907 (actual)

## Conditions studied

- Ewing's Sarcoma

## Interventions

- **DRUG:** Zoledronic acid
- **DRUG:** Busulfan
- **DRUG:** Treosulfan

## Key facts

- **NCT ID:** NCT00987636
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-01
- **Primary completion:** 2019-03-31
- **Final completion:** 2019-03-31
- **Target enrollment:** 907 (ACTUAL)
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00987636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00987636, "Study in Localized and Disseminated Ewing Sarcoma". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00987636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*